בקשת ציטוטים

Citação APA (7ª ed.)
Gilmore, R., Murali, A., Etchegaray, A., Swe, E., An, Y., & Begun, J. (2025). Upadacitinib and vedolizumab combination therapy for the management of refractory ulcerative colitis and Crohn’s disease. Korean Association for the Study of Intestinal Diseases.
Citação do estilo Chicago (17ª ed.)
Gilmore, Robert, Amrutha Murali, Amirah Etchegaray, Ei Swe, Yoon-Kyo An, e Jakob Begun. Upadacitinib and Vedolizumab Combination Therapy for the Management of Refractory Ulcerative Colitis and Crohn’s Disease. Korean Association for the Study of Intestinal Diseases, 2025.
Citação MLA (9ª ed.)
Gilmore, Robert, et al. Upadacitinib and Vedolizumab Combination Therapy for the Management of Refractory Ulcerative Colitis and Crohn’s Disease. Korean Association for the Study of Intestinal Diseases, 2025.
אזהרה: ציטוטים אלה לעיתים לא מדויקים ב 100%.